Generated automatically from the NAFDAC register, WHO alerts and community data as of today. Not medical advice — always follow your doctor or pharmacist.
Add the expiry date printed on your pack for a full Trust Score — or look up uses, side effects and cheaper generics.
SPAQ-Co Dispersible Tablets 500 mg/25 mg/153 mg contains Amodiaquine (Amodiaquine Hydrochloride); Sulfadoxine; Pyrimethamine (153 mg; 500 mg; 25 mg), as dispersible tablet, according to its NAFDAC registration record.
Yes. SPAQ-Co Dispersible Tablets 500 mg/25 mg/153 mg is listed on the NAFDAC register under registration number B4-6482, and its registration is active as of 6 November 2026.
No WHO falsified or substandard medical product alert currently matches SPAQ-Co Dispersible Tablets 500 mg/25 mg/153 mg in our automatically synced alert list.
Run a free authenticity scan with the NAFDAC number B4-6482, your pack's expiry date and batch number to get a Trust Score, compare the pack with the NAFDAC record (ingredient, strength, form, manufacturer), and buy only from licensed pharmacies.
Reviews are personal experiences from RxVerify users, not medical advice. Report side effects to your doctor and to NAFDAC.